Companies: 10,795·Total market cap: $144.5T
Nuvalent, Inc.

Nuvalent, Inc.

NUVLNASDAQHealthcare● Active
$89.14
$-1.81(-1.99%)
Market Cap$6.6B
P/E Ratio
52W High$113.015
52W Low$71.13

Nuvalent, Inc. (NUVL) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

nuvl · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 14 Wall Street analysts in the past 3 months

SellBuy

Buy

14 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
14
Hold
0
Sell
0
Strong Sell
0
Total: 14 · Buy rate: 100.0%

12-Month Price Target

High

$189

Consensus

$177

+99.9% upside

Low

$165

Median: $177 · Last Close: $88.55

The Nuvalent, Inc. (NUVL) analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month NUVL price target is $177.00, representing +99.9% upside from the current price of $88.55.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $177 (99.9%)

Consensus Target

$177.00

99.9% upside

High Target

$189

113.4%

Low Target

$165

86.3%

Current Price

$88.55

as of today

Based on analyst price targets, the NUVL stock price prediction for the next 12 months ranges from $165 to $189. The consensus NUVL price forecast of $177.00 implies 99.9% upside from the current price of $88.55.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$84.125.00%

1-day model range: $83.57–$84.68. Peak: $84.68 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$111+25.2%
2028$128+44.0%
2029$139+57.1%
2030$147+65.6%
2031+71.0%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)36.5Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NUVL · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$91.01SELL
MA 10$98.00SELL
MA 20$100.28SELL
MA 50$102.26SELL
MA 100$102.23SELL
MA 200$97.76SELL
Current $NUVL · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$92.10SELL
EMA 10$95.39SELL
EMA 20$98.46SELL
EMA 50$100.82SELL
EMA 100$100.73SELL
EMA 200$97.30SELL
Current $NUVL · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Wedbush2026-05-28
Maintains
OutperformOutperform
HC Wainwright & Co.2026-04-21
Maintains
BuyBuy
Wedbush2026-04-08
Maintains
OutperformOutperform
Cantor Fitzgerald2026-02-27
Maintains
OverweightOverweight
JP Morgan2025-12-19
Maintains
OverweightOverweight
Guggenheim2025-11-18
Maintains
BuyBuy
Baird2025-11-18
Maintains
OutperformOutperform
Goldman Sachs2025-11-18
Maintains
BuyBuy
HC Wainwright & Co.2025-11-17
Maintains
BuyBuy
Stifel2025-11-17
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Nuvalent, Inc. (NUVL) stock. Of the recent 44 rating actions, 2 were upgrades and 0 were downgrades. 14 analysts currently cover NUVL.

Analyst Recommendation Trends

Buy ratings312
Hold ratings00
Sell ratings00

NUVL analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$12M

↓ 97.7% YoY

Revenue Next Year

$181M

↑ 1450.7% YoY

EPS This Year

$-5.70

EPS Next Year

$-4.47

↓ 21.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NUVL EPS of $-5.70 for the current fiscal year, based on estimates from 14 analysts. The NUVL revenue forecast is $12M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The NUVL stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NUVL price target is $177.00 (+99.9% upside), with an analyst consensus of Buy.

The NUVL short-term stock prediction for tomorrow is $84.12 (-5.00%). The NUVL stock price prediction for 2027 estimates an average of $111. The NUVL stock prediction for 2030 projects a range of $136–$157.

Nuvalent, Inc. trades on NASDAQ under the ticker NUVL. The NUVL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

NUVL forecast · 8 questions

According to 14 Wall Street analysts, the average 12-month NUVL price target is $177.00, with a high forecast of $189.00 and a low of $165.00. The median price target is shown in the chart above when available. This implies +99.9% potential upside from the current price of $88.55.

NUVL price targetWhat is NUVL price targetNUVL analyst price targetNUVL 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.